Melrose Launches £73 Million Compensation Programme After GKN Aerospace Chemical Incident in California
Key Points
Melrose will launch a £73.4 million ($100 million) compensation programme for California residents.
The GKN Aerospace incident cut H1 2026 revenue by £16 million and profit by £9 million.
Melrose expects £25 million to £30 million in extra H2 2026 costs from the incident.
Full manufacturing at the Garden Grove site restarts on September 28, 2026.
Melrose Industries will launch a compensation programme worth up to £73.4 million ($100 million). The FTSE 100 group’s GKN Aerospace unit suffered a chemical incident at its Garden Grove, California site in May. Melrose said the claims programme opens within weeks and runs into 2027.
What Triggered the Compensation Programme
An overheating chemical tank at GKN Aerospace’s Garden Grove facility triggered an emergency services response in late May 2026. Local authorities issued an evacuation order for surrounding residents and businesses. Melrose confirmed the incident forced a temporary halt to manufacturing at the site.
The compensation programme will cover residents and businesses affected by the May evacuation. Eligible claims include hotel stays, meals, transport costs, and lost wages. Melrose expects the claims process to remain open well into 2027.
Financial Impact Already Showing Up
First-Half Results Took a Direct Hit
The California incident reduced Melrose’s interim revenue by £16 million during the first half of 2026. Adjusted operating profit fell by £9 million as a direct result. Despite the hit, Melrose posted an 18% jump in half-year adjusted earnings and 10% sales growth.
More Costs Expected in H2
Melrose warned last month it expects extra costs of £25 million to £30 million in the second half of 2026. The estimate covers both the California incident and reduced operating capacity at the site. Melrose also paused its £175 million share buyback programme while assessing the full financial impact.
Manufacturing Restart Timeline
Melrose plans to restart full manufacturing operations at the Garden Grove site on September 28, 2026. GKN Aerospace produces engine parts for jet fighters, military helicopters, and civil aircraft. The extended shutdown has weighed on production schedules tied to both defense and commercial aviation programs.
Related Aerospace and Defense Stocks
Investors tracking Melrose often compare its aerospace exposure against other UK and European defense manufacturers listed on major exchanges:
- Rolls-Royce Holdings (LSE: RR): a direct competitor in aircraft engine components and services
- BAE Systems: UK defense peer with overlapping military aerospace contracts
- Safran: French aerospace group competing in engine and equipment manufacturing
Final Word
Melrose’s £73.4 million compensation programme addresses immediate community impact from the Garden Grove incident. The financial hit stays contained so far, with H1 growth still outpacing the disruption. Full manufacturing recovery by late September will be the key metric to watch next.
Disclaimer:
The content shared by Meyka AI PTY LTD is for research and informational purposes only. Meyka is not a financial advisory service, and the information provided should not be treated as investment or trading advice.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)